Carboplatin and Paclitaxel With or Without ISIS 3521 in Treating Patients With Non-Small Cell Lung Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. ISIS 3521 may help kill more cancer cells by making tumor cells
more sensitive to chemotherapy. It is not yet known if carboplatin and paclitaxel are more
effective with or without ISIS 3521.
PURPOSE: Randomized phase III trial to compare the effectiveness of carboplatin and
paclitaxel with or without ISIS 3521 in treating patients who have stage IIIB or stage IV
non-small cell lung cancer.